Details for New Drug Application (NDA): 006412
✉ Email this page to a colleague
NDA 006412 describes DECAPRYN, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the DECAPRYN profile page.
The generic ingredient in DECAPRYN is doxylamine succinate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxylamine succinate profile page.
The generic ingredient in DECAPRYN is doxylamine succinate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxylamine succinate profile page.
Summary for 006412
| Tradename: | DECAPRYN |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | doxylamine succinate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 006412
Profile for product number 014
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 015
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 12.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
